gemcitabine has been researched along with ex 527 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Oon, CE; Östman, A; Prakash, J; Strell, C; Yeong, KY | 1 |
2 other study(ies) available for gemcitabine and ex 527
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo.
Topics: Animals; Apoptosis; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Deoxycytidine; Disease Models, Animal; Drug Synergism; Epithelial-Mesenchymal Transition; Gemcitabine; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Male; Mice; Micronucleus Tests; Pancreatic Neoplasms; Sirtuin 1 | 2015 |